Mapping of magnetic relaxation within the myocardial tissue using T1 (and T2) mapping using cardiovascular magnetic resonance (CMR) are novel measures of quantifiable (scalable) myocardial tissue characterisation. Evidence suggests that myocardial mapping could be useful in detection of diffuse myocardial disease, complementing late gadolinium enhancement (LGE) as the tool for regional myocardial disease. A handful of studies, three single centre study of a single T1 index with outcomes and one multicentre study for all indices reported strong associations with all cause mortality and heart failure. These studies were based on a single-vendor platform and were using a single sequence. The main unknowns pertaining the successful translation of this technique and the transferability of the methodology beyond a single centre and lack of outcome evidence from broad and large populations. In this study, we will assess the diagnostic accuracy of T1 (and T2) mapping measurements in health and disease, and the prognostic relevance of T1 mapping measurements by associations with outcome. This study is builds upon/integrates the evidence of the NCT02407197 study, which remains active for follow-up, but is currently no longer recruiting.
Study Type
OBSERVATIONAL
Enrollment
8,000
Kerckhoff Hospital
Bad Nauheim, Hesse, Germany
Institute for experimental and translational cardiovascular imaging
Frankfurt am Main, Hesse, Germany
Survival
number of deaths
Time frame: 1 year
Survival
number of deaths
Time frame: 5 year
Rate of Heart Failure events
Number of participants with events including death and Hospitalisation due to Heart Failure
Time frame: 1 year
Rate of Heart Failure events
Number of participants with events including death and Hospitalisation due to Heart Failure
Time frame: 5 year
Rate of Arrhythmia
Number of participants with events of documented Sudden Cardiac Death, appropriate ICD discharge, sustained VT
Time frame: 1 year
Rate of Arrhythmia
Number of participants with events including documented Sudden Cardiac Death, appropriate ICD discharge, sustained VT
Time frame: 5 year
Rate of death due to to cardiovascular causes
Number of participants with death due to myocardial infarction, heart failure, arrhythmia
Time frame: 1 year
Rate of death due to to cardiovascular causes
Number of participants with death due to myocardial infarction, heart failure, arrhythmia
Time frame: 5 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.